Medexus Pharmaceuticals Reports Operating and Financial Results for the First Quarter of Fiscal 2020

NEXT STORY
Chi-Med Initiates a Phase I Trial of HMPL-523 in Patients with Immune Thrombocytopenia (ITP) in China
PREV STORY
Tempus Expands Leadership Team With the Appointment of Joel Dudley, PhD, as Senior Vice President of Research
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Selecta Biosciences to Present New Five Monthly Dose Phase 2 Data for SEL-212 in Chronic, Severe Gout at Upcoming 2018 ACR Annual Meeting

Data continue to suggest sustained serum uric acid (sUA) level reductions and low number ...

author_avatar
NASDAQ Market News

In Vitro Diagnostics (IVD) Market Worth $87.21 Billion by 2024, Growing at a CAGR of 5.7% – Global Opportunity Analysis and Industry Forecasts by Meticulous Research®

author_avatar
NASDAQ Market News

Genome Editing Market to grow at 14% CAGR and exceed $7.5 billion by 2024: Global Market Insights, Inc.

Ocean View, Delaware, Aug. 10, 2017 (GLOBE NEWSWIRE) -- The Industry Analysis report “Gene ...

author_avatar
NASDAQ Market News